Skip to main content
OpenTrials
Completed

NCT Number: NCT01120730

Fluid Resuscitation With HES 200/0.5 10% in Severe Burn Injury

HES 200/0.5 10% is equal to ringers lactat solution.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Survival Female Urogenital Diseases Female Urogenital Diseases and Pregnancy Complications Kidney Diseases Male Urogenital Diseases Renal Failure Renal Insufficiency Urogenital Diseases Urologic Diseases

Age range

18 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University Hospital Zurich

Zurich, 8091, Switzerland

About this study

30 Patients were enrolled to the study, either to the hyperoncotic HES 200/0.5 (10%) group or to the crystalloids only group. After a treatment protocol of 72 hours we collected data about complications like pulmonary failure and abdominal compartment syndrome. Furthermore, we addressed the question of incidence of mortality and renal failure.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • All burn victims with burned surface area bigger than 20%

Exclusion criteria

  • Pregnancy

Treatment and study plan

fluid resuscitation

Drug

fluid resuscitation with HES

Primary outcomes

  1. Intensive care unit mortality

    Time frame: 28 days

    28 days

Secondary outcomes

  1. fluid amount during the first 72 hours

    Time frame: 28 days

    Fluid resuscitation after burn

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Important dates

Study start
1997
Primary completion
1998
Study completion
2009
First posted
May 11, 2010
Registry last updated
May 11, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.